Data Integrity in the Pharma Space

Pharmaceutical companies and contract manufacturing organizations must work within Good Manufacturing or Laboratory Practice regulations to ensure the safety and quality of pharmaceutical products. Yet over the past 15 years, there have been many data integrity breaches. Now, regulatory authorities are encouraging pharmaceutical companies to work electronically to ensure data integrity.

Spotlight

The Karis Group

The Karis Group is an Austin, Texas based professional services firm with over fourteen years of experience providing our flagship Patient Advocacy or Bill Mediation service. We service clients nationwide, from employers, insurers and healthcare sharing organizations to benefit resellers, wholesalers and program administrators. Through these client relationships, we mediate on behalf of thousands of individuals (patients, members or employees) each year on the patient responsibility or out-of-pocket portion of their medical bills. Last year alone, we saved these individuals over $24 million dollars while helping them shoulder the stressful and time consuming burden of working with healthcare providers and government agencies to resolve their medical bills.

OTHER WHITEPAPERS
news image

National Council for Prescription Drug Programs

whitePaper | May 12, 2022

This document is Copyright © 2022 by the National Council for Prescription Drug Programs (NCPDP). It may be freely redistributed in its entirety provided this copyright notice is not removed.

Read More
news image

Asia Pacific – Clinical trial landscape

whitePaper | November 8, 2022

The Asia-Pacific region has emerged as a clinical trial hub due to the ease of regulatory compliance, low trial costs, rising patient population, and the availability of top clinical institutions.

Read More
news image

Advancing drug development using in silico modeling

whitePaper | June 22, 2022

The technologic and pharmacologic advances that have enabled researchers to take aim at previously untreatable diseases have contributed to an increase in the number of molecules in the development pipeline that are challenging and difficult to manufacture.

Read More
news image

New Active Substances Launched During 2021

whitePaper | June 27, 2022

Following on from our review of trends in the current pharmaceutical R&D pipeline this supplement takes a look at the industry’s success stories of 2021

Read More
news image

Shining a Light on Lipid Nanoparticle Characterization

whitePaper | October 3, 2022

Next-Generation Synthetic Biology Workflow Platform Codex DNA’s BioXp 9600 system is a next-generation high throughput platform intended for automated synthesis of gene fragments and clones from digital sequences.

Read More
news image

Pharma R And D Review

whitePaper | February 11, 2021

Welcome to Pharmaprojects’ 2021 review of trends in pharmaceutical R&D. For almost 30 years now, I’ve been taking an annual look at the evolution of pharma R&D, and in this article I’ll examine the state of play at the start of 2021.

Read More

Spotlight

The Karis Group

The Karis Group is an Austin, Texas based professional services firm with over fourteen years of experience providing our flagship Patient Advocacy or Bill Mediation service. We service clients nationwide, from employers, insurers and healthcare sharing organizations to benefit resellers, wholesalers and program administrators. Through these client relationships, we mediate on behalf of thousands of individuals (patients, members or employees) each year on the patient responsibility or out-of-pocket portion of their medical bills. Last year alone, we saved these individuals over $24 million dollars while helping them shoulder the stressful and time consuming burden of working with healthcare providers and government agencies to resolve their medical bills.

Events